Anticancer Therapy–Related Increases in Arterial Stiffness: A Systematic Review and Meta‐Analysis
Background Cardio‐oncology is a clinical discipline focused primarily on the early detection of anticancer therapy–related cardiomyopathy. However, there is growing evidence that the direct adverse consequences extend beyond the myocardium to affect the vasculature, but this evidence remains limited...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-07-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.119.015598 |
| _version_ | 1818775958171156480 |
|---|---|
| author | Shannon K. Parr Jia Liang Keri L. Schadler Susan C. Gilchrist Catherine C. Steele Carl J. Ade |
| author_facet | Shannon K. Parr Jia Liang Keri L. Schadler Susan C. Gilchrist Catherine C. Steele Carl J. Ade |
| author_sort | Shannon K. Parr |
| collection | DOAJ |
| description | Background Cardio‐oncology is a clinical discipline focused primarily on the early detection of anticancer therapy–related cardiomyopathy. However, there is growing evidence that the direct adverse consequences extend beyond the myocardium to affect the vasculature, but this evidence remains limited. In addition, there remains a paucity of clinically based strategies for monitoring vascular toxicity in these patients. Importantly, arterial stiffness is increasingly recognized as a surrogate end point for cardiovascular disease and may be an important vascular outcome to consider. Therefore, the aim of this systematic review and meta‐analysis was to summarize evidence of increased arterial stiffening with anticancer therapy and evaluate the effect of treatment modifiers. Methods and Results A total of 19 longitudinal and cross‐sectional studies that evaluated arterial stiffness both during and following anticancer therapy were identified using multiple databases. Two separate analyses were performed: baseline to follow‐up (12 studies) and control versus patient groups (10 studies). Subgroup analysis evaluated whether stiffness differed as a function of treatment type and follow‐up time. Standard mean differences and mean differences were calculated using random effect models. Significant increases in arterial stiffness were identified from baseline to follow‐up (standard mean difference, 0.890; 95% CI, 0.448–1.332; P<0.0001; mean difference, 1.505; 95% CI, 0.789–2.221; P≤0.0001) and in patient versus control groups (standard mean difference, 0.860; 95% CI, 0.402–1.318; P=0.0002; mean difference, 1.437; 95% CI, 0.426–2.448; P=0.0052). Subgroup analysis indicated differences in arterial stiffness between anthracycline‐based and non‐anthracycline‐based therapies (standard mean difference, 0.20; 95% CI, 0.001–0.41; P=0.048), but not follow‐up time. Conclusions Significant arterial stiffening occurs following anticancer therapy. Our findings support the use of arterial stiffness as part of a targeted vascular imaging strategy for the identification of early cardiovascular injury during treatment and for the detection of long‐term cardiovascular injury into survivorship. |
| first_indexed | 2024-12-18T11:05:18Z |
| format | Article |
| id | doaj.art-ad8d5ee336f342a584fc260e1f4ca9cb |
| institution | Directory Open Access Journal |
| issn | 2047-9980 |
| language | English |
| last_indexed | 2024-12-18T11:05:18Z |
| publishDate | 2020-07-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| spelling | doaj.art-ad8d5ee336f342a584fc260e1f4ca9cb2022-12-21T21:10:07ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802020-07-0191410.1161/JAHA.119.015598Anticancer Therapy–Related Increases in Arterial Stiffness: A Systematic Review and Meta‐AnalysisShannon K. Parr0Jia Liang1Keri L. Schadler2Susan C. Gilchrist3Catherine C. Steele4Carl J. Ade5Department of Kinesiology College of Health and Human Sciences Kansas State University Manhattan KSDepartment of Statistics Kansas State University Manhattan KSDivision of Pediatrics Department of Pediatrics The University of Texas MD Anderson Cancer Center Houston TXDepartment of Clinical Cancer Prevention and Department of Cardiology The University of Texas MD Anderson Cancer Center Houston TXDepartment of Food, Nutrition, Dietetics, Health Kansas State University Manhattan KSDepartment of Kinesiology College of Health and Human Sciences Kansas State University Manhattan KSBackground Cardio‐oncology is a clinical discipline focused primarily on the early detection of anticancer therapy–related cardiomyopathy. However, there is growing evidence that the direct adverse consequences extend beyond the myocardium to affect the vasculature, but this evidence remains limited. In addition, there remains a paucity of clinically based strategies for monitoring vascular toxicity in these patients. Importantly, arterial stiffness is increasingly recognized as a surrogate end point for cardiovascular disease and may be an important vascular outcome to consider. Therefore, the aim of this systematic review and meta‐analysis was to summarize evidence of increased arterial stiffening with anticancer therapy and evaluate the effect of treatment modifiers. Methods and Results A total of 19 longitudinal and cross‐sectional studies that evaluated arterial stiffness both during and following anticancer therapy were identified using multiple databases. Two separate analyses were performed: baseline to follow‐up (12 studies) and control versus patient groups (10 studies). Subgroup analysis evaluated whether stiffness differed as a function of treatment type and follow‐up time. Standard mean differences and mean differences were calculated using random effect models. Significant increases in arterial stiffness were identified from baseline to follow‐up (standard mean difference, 0.890; 95% CI, 0.448–1.332; P<0.0001; mean difference, 1.505; 95% CI, 0.789–2.221; P≤0.0001) and in patient versus control groups (standard mean difference, 0.860; 95% CI, 0.402–1.318; P=0.0002; mean difference, 1.437; 95% CI, 0.426–2.448; P=0.0052). Subgroup analysis indicated differences in arterial stiffness between anthracycline‐based and non‐anthracycline‐based therapies (standard mean difference, 0.20; 95% CI, 0.001–0.41; P=0.048), but not follow‐up time. Conclusions Significant arterial stiffening occurs following anticancer therapy. Our findings support the use of arterial stiffness as part of a targeted vascular imaging strategy for the identification of early cardiovascular injury during treatment and for the detection of long‐term cardiovascular injury into survivorship.https://www.ahajournals.org/doi/10.1161/JAHA.119.015598arterial stiffnesscancer therapycardiotoxicitypulse wave velocityvascular toxicity |
| spellingShingle | Shannon K. Parr Jia Liang Keri L. Schadler Susan C. Gilchrist Catherine C. Steele Carl J. Ade Anticancer Therapy–Related Increases in Arterial Stiffness: A Systematic Review and Meta‐Analysis Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease arterial stiffness cancer therapy cardiotoxicity pulse wave velocity vascular toxicity |
| title | Anticancer Therapy–Related Increases in Arterial Stiffness: A Systematic Review and Meta‐Analysis |
| title_full | Anticancer Therapy–Related Increases in Arterial Stiffness: A Systematic Review and Meta‐Analysis |
| title_fullStr | Anticancer Therapy–Related Increases in Arterial Stiffness: A Systematic Review and Meta‐Analysis |
| title_full_unstemmed | Anticancer Therapy–Related Increases in Arterial Stiffness: A Systematic Review and Meta‐Analysis |
| title_short | Anticancer Therapy–Related Increases in Arterial Stiffness: A Systematic Review and Meta‐Analysis |
| title_sort | anticancer therapy related increases in arterial stiffness a systematic review and meta analysis |
| topic | arterial stiffness cancer therapy cardiotoxicity pulse wave velocity vascular toxicity |
| url | https://www.ahajournals.org/doi/10.1161/JAHA.119.015598 |
| work_keys_str_mv | AT shannonkparr anticancertherapyrelatedincreasesinarterialstiffnessasystematicreviewandmetaanalysis AT jialiang anticancertherapyrelatedincreasesinarterialstiffnessasystematicreviewandmetaanalysis AT kerilschadler anticancertherapyrelatedincreasesinarterialstiffnessasystematicreviewandmetaanalysis AT susancgilchrist anticancertherapyrelatedincreasesinarterialstiffnessasystematicreviewandmetaanalysis AT catherinecsteele anticancertherapyrelatedincreasesinarterialstiffnessasystematicreviewandmetaanalysis AT carljade anticancertherapyrelatedincreasesinarterialstiffnessasystematicreviewandmetaanalysis |